Gene · 5451
Papers3,509
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,509
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Comprehensive analysis of the deleterious nonsynonymous, non-coding SNPs and cancer variants of human aldo-keto reductase type 1 (AKR1C1) protein and their probable association with disease risk and progression: a computational study. | Biochem Biophys Rep | 2026 | 41756011 | PubTator, text mining | PubMed |
| MicroRNA as Potential Biomarkers and Their Pathogenesis in Multiple System Atrophy. | Int J Mol Sci | 2026 | 41752011 | PubTator, text mining | PubMed |
| The KT Jeang retrovirology prize 2025: Carine Van Lint. | Retrovirology | 2026 | 41749325 | PubTator, text mining | PubMed |
| A non-transcriptional mitotic function of POU/Oct factors ensures spindle assembly and chromosome segregation. | J Cell Sci | 2026 | 41725553 | PubTator, text mining | PubMed |
| Nanoparticle approaches for hepatitis therapy and clinical translation. | Discov Nano | 2026 | 41649705 | PubTator, text mining | PubMed |
| Cisplatin disrupts OCT1-DNMT1-piRNA epigenetic regulatory axis to suppress GAB2-mediated aggressiveness in OSCC. | Arch Biochem Biophys | 2026 | 41638543 | PubTator, text mining | PubMed |
| KSHV and cancer: understanding the oncogenic machinery for next-generation diagnostic tools and therapies. | Arch Microbiol | 2026 | 41563473 | PubTator, text mining | PubMed |
| Role of hsa-miR-122-5p in chronic thromboembolic pulmonary hypertension and chronic thromboembolic disease: Targeting PIK3CG in the PI3K/Akt signaling pathway. | Medicine (Baltimore) | 2026 | 41560055 | PubTator, text mining | PubMed |
| Engineered LINC MIR503HG-loaded extracellular vesicles maintain stemness and pluripotency during long-term hiPSCs culture. | Bioact Mater | 2026 | 41551196 | PubTator, text mining | PubMed |
| Expression and function of CYP enzymes and hepatobiliary transporters in an improved long-term sandwich culture hepatocyte model. | Sci Rep | 2026 | 41545475 | PubTator, text mining | PubMed |
| Functional characterization of a multi-cancer risk locus on chromosome band 2q33.1 near CASP8. | bioRxiv | 2026 | 41542517 | PubTator, text mining | PubMed |
| MicroRNA-138 regulation promotes the efficacy of oncolytic herpes virus G47Δ for malignant brain tumor therapy. | Mol Ther Oncol | 2026 | 41542035 | PubTator, text mining | PubMed |
| Physiologically-Based Pharmacokinetic Modeling of the PARP Inhibitor Niraparib. | CPT Pharmacometrics Syst Pharmacol | 2026 | 41531282 | PubTator, text mining | PubMed |
| Analysis and identification of circRNA-regulated ceRNA networks associated with the virulence differences between PRV FA and FB strains. | BMC Vet Res | 2026 | 41514351 | PubTator, text mining | PubMed |
Integrated cytotoxicity screening and in silico analysis of coumarin nucleoside conjugates as computationally modeled VEGFR-2 inhibitors: oncocyte cytotoxicity, molecular docking, and dynamics simulation studies. | In Silico Pharmacol | 2026 | 41431638 | PubTator, text mining | PubMed |
| Ternary complexes in protein-DNA interactions: Kinetics and mechanisms. | J Biol Chem | 2026 | 41371343 | PubTator, text mining | PubMed |
| Structural Characterization of Protein-Nucleic Acid Complexes: An Overview of the Recent Innovation in the Analytic Methods. | Int J Mol Sci | 2025 | 41373622 | PubTator, text mining | PubMed |
| Laminar double hydroxide-loaded miR-654-3p targets POU2F1-mediated metabolic reprogramming against colorectal cancer. | Bioorg Chem | 2025 | 41260064 | PubTator, text mining | PubMed |
| Predicted molecules followed by experimental validation for protecting human neurons from oxidative stress-induced cytotoxicity. | Proc Natl Acad Sci U S A | 2025 | 41183202 | PubTator, text mining | PubMed |
| NCAPH-YAP1 interaction promotes breast cancer stemness and tumor progression. | Stem Cell Res Ther | 2025 | 40999529 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5451/papers?page=2